Investors support Alterity Therapeutics Parkinsons drug
MELBOURNE: Investors have backed Alterity Therapeutics (ASX: ATH) with the company securing $35 million to
MELBOURNE: Investors have backed Alterity Therapeutics (ASX: ATH) with the company securing $35 million to